Snowball logo
logo
6541

Tanvex BioPharma Inc

6541 TW
NT$38.10-NT$0.80  (2.06%)
Estimate
EPS
-5.51
Beta
0.215
Growth
Revenue, YoY
166.39%
Net income, YoY
16.54%
FCF, YoY
-63.14%
About the company
Ticker
6541
ISIN
KYG8676P1037
Country
Cayman Islands
Sector (GICS)
Healthcare
Tanvex BioPharma, Inc., a pharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar products in Taiwan and the United States. The company focuses on delivering biopharmaceuticals with biosimilars targeting neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. It also engages in contract development and manufacturing of biological medicines. The company was founded in 2011 and is headquartered in George Town, the Cayman Islands.

Frequently asked questions

What sector does Tanvex BioPharma Inc (6541) operate in?

Tanvex BioPharma Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Tanvex BioPharma Inc (6541) current stock price?

As of the latest data, Tanvex BioPharma Inc stock price is NT$38.10, with a previous close of NT$38.90. Tanvex BioPharma Inc lost -NT$0.80 in the last trading session, representing a -2.06% loss.

What is Tanvex BioPharma Inc (6541) current market capitalization?

Tanvex BioPharma Inc market cap is approximately 10.10 billion.

What is Tanvex BioPharma Inc (6541) Earnings Per Share (EPS)?

The trailing EPS is -NT$5.51.

What is Tanvex BioPharma Inc (6541) EBITDA?

Tanvex BioPharma Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -312.16 million.

Does Tanvex BioPharma Inc (6541) pay dividends?

No. Tanvex BioPharma Inc does not pay a dividend.

What is Tanvex BioPharma Inc (6541) beta (volatility) score?

Tanvex BioPharma Inc has a beta of 0.215, indicating lower volatility than the overall market.